Nature Biotechnology 'Under Consideration': What Each Status Means and When to Expect a Decision
If your Nature Biotechnology submission shows Under Consideration, here is what each status means, the typical timeline, and what passing the desk screen signals about your paper.
Senior Researcher, Oncology & Cell Biology
Author context
Specializes in manuscript preparation and peer review strategy for oncology and cell biology, with deep experience evaluating submissions to Nature Medicine, JCO, Cancer Cell, and Cell-family journals.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Decision cue: Nature Biotechnology desk rejects approximately 70% of submissions. If your paper shows "Under Consideration" past the 10-day mark, you have very likely survived the desk screen. The journal publishes biotechnology research that is technically innovative and has clear practical implications. The editorial test is not just scientific rigor but whether the technology works, scales, and matters for real-world applications.
Check your next submission's readiness while you wait.
Nature Biotechnology review pipeline
Status | What is happening | Typical duration |
|---|---|---|
Received | Administrative processing | 1 to 2 days |
Under Consideration | Editor evaluating, consulting team, possibly inviting reviewers | Days to weeks |
Under Review (if shown) | Sent to external reviewers | 4 to 8 weeks |
Decision in Process | Editor reviewing reports | 3 to 7 days |
Decision Made | Check email | Same day |
Like other Nature journals, "Under Consideration" covers the entire editorial assessment period. The status does not distinguish between "editor is reading it" and "reviewers have been invited."
What Nature Biotechnology editors screen for
Nature Biotechnology sits at the intersection of science and application. Editors evaluate:
- Technical innovation: Is this a genuinely new technology, method, or approach? Incremental improvements to existing tools are usually redirected to more specialized journals.
- Practical applicability: Does the technology work in realistic conditions, not just in ideal laboratory settings? A tool that works beautifully in one cell line but has not been tested in primary cells or in vivo faces skepticism.
- Validation depth: Has the technology been validated with appropriate controls, benchmarked against existing alternatives, and demonstrated in multiple contexts?
- Scalability and usability: Can other labs adopt this? Is the technology accessible, or does it require specialized equipment that limits adoption?
The journal is particularly strong in areas like CRISPR tool development, single-cell technologies, computational methods for biological data, synthetic biology, and therapeutic development platforms.
What happens during peer review
Papers that pass the desk go to 2 to 3 reviewers selected for expertise in both the technology and the application domain. Nature Biotechnology reviewers evaluate:
- technical novelty (not just an improvement, but a new capability)
- validation rigor (multiple cell types, primary cells, in vivo, head-to-head with existing tools)
- reproducibility (can another lab replicate this with the described protocol?)
- practical impact (does this enable experiments or applications that were not previously feasible?)
- presentation clarity (is the technology accessible to a broad biotechnology audience?)
Common reviewer requests at Nature Biotechnology
Reviewers frequently ask for:
- additional validation in a different biological system or cell type
- head-to-head comparison with the current gold standard method
- demonstration of the technology by a user who did not develop it (to test usability)
- longer-term performance data (stability, reliability over time)
- discussion of limitations and failure modes
These are substantive requests that often require weeks to months to address. If your paper passes the desk at Nature Biotechnology, prepare for a revision period that may require new experiments.
When to worry, when to wait
Situation | What it likely means |
|---|---|
Under Consideration, day 5 | Editor reading or discussing with team |
Under Consideration, day 10+ | Likely passed desk, reviewers being invited |
Under Consideration, day 14+ | Active review likely underway |
Under Consideration, day 45+ | Possible reviewer delay. Follow up politely |
Decision in Process | Reports received, decision within days |
Understanding the decision
- Revise: the most common outcome for papers that pass review at Nature journals. Revisions typically require additional validation experiments, which may take months.
- Reject after review: the technology did not meet the novelty or validation threshold. The decision letter includes detailed reviewer feedback.
- Redirect: the editor may suggest Nature Methods (if the advance is primarily methodological without broad biological application), Nature Communications (if the advance is solid but not top-tier), or a specialty journal.
What to do while waiting
- do not submit the same paper elsewhere
- prepare for reviewer requests for additional validation: more cell types, more organisms, head-to-head comparison with existing tools
- Nature Biotechnology revisions for technology papers often require new benchmarking experiments
- if the technology has a preprint, you can continue to present it at conferences
Related guides
Sources
On this page
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.